Estimates Revisions Enlivex

Stocks

ENLV

IL0011319527

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-10 EDT			5-day change	1st Jan Change
6.860 ^USD	-7.30%		-13.32%	-34.96%

06-15	Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis	MT
06-01	Enlivex Ltd. Presents Durable 6-Month Efficacy Data For Allocetra In Knee Osteoarthritis Phase IIa Trial	CI

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

EBIT - Evolution of Analysts' Estimates

Turnover

Earnings Per Share (EPS)

EBIT

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener